Literature DB >> 16382373

Botulinum toxin treatment for oropharyngeal dysphagia due to tetanus.

Domenico A Restivo, Rosario Marchese-Ragona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16382373     DOI： 10.1007/s00415-005-0975-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Successful botulinum toxin treatment of dysphagia in oculopharyngeal muscular dystrophy.

Authors:  D A Restivo; R Marchese Ragona; A Staffieri; D de Grandis
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

2.  Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.

Authors:  Domenico A Restivo; Agostino Palmeri; Rosario Marchese-Ragona
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 3.  Tetanus: pathophysiology and management.

Authors:  M E Ernst; M E Klepser; M Fouts; M N Marangos
Journal:  Ann Pharmacother       Date:  1997-12       Impact factor: 3.154

4.  Otolaryngologic aspects of tetanus.

Authors:  Kemalettin Aydin; Rahmet Caylan; Refik Caylan; Devrim Bektas; Iftihar Koksal
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-08-10       Impact factor: 2.503

Review 5.  Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Authors:  R Pellizzari; O Rossetto; G Schiavo; C Montecucco
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237
  5 in total
  2 in total

Review 1.  Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms.

Authors:  Bjørnar Hassel
Journal:  Toxins (Basel)       Date:  2013-01-08       Impact factor: 4.546

Review 2.  Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy.

Authors:  Vito Pavone; Gianluca Testa; Domenico A Restivo; Luca Cannavò; Giuseppe Condorelli; Nicola M Portinaro; Giuseppe Sessa
Journal:  Front Pharmacol       Date:  2016-02-19       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.